Spotlight
Clinical
CME/CE
Subscribe
- Benign Prostatic Hyperplasia
- Hormone Therapy
- Genomic Testing
- Next-Generation Imaging
- UTUC
- OAB and Incontinence
- Genitourinary Cancers
- Kidney Cancer
- Men's Health
- Pediatrics
- Female Urology
- Sexual Dysfunction
- Kidney Stones
- Urologic Surgery
- Bladder Cancer
- Benign Conditions
- Prostate Cancer
The Role for Systematic Biopsy Plus MRI-Targeted Procedures
Focusing on the role of systematic biopsy, the panel provides clinical insights on biopsy practice patterns after encountering suspicious-looking areas on MRI.
EP: 1.The Role of Imaging in Diagnosing and Staging Prostate Cancer
EP: 2.Advances in Prostate Biopsy
EP: 3.Benefits of Incorporating Fusion-Guided Biopsy into Practice
EP: 4.A Review of the Data for Fusion-Based Biopsy Procedures
EP: 5.Understanding Differences in Fusion-Guided Biopsy Technologies
Now Viewing
EP: 6.The Role for Systematic Biopsy Plus MRI-Targeted Procedures
EP: 7.Fusion-Guided Biopsies in Active Surveillance for Patients With Prostate Cancer
EP: 8.Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy
Video content above is prompted by the following questions:
- What are some of the key differences between organ-based tracking and probe tracking technologies used in the current fusion-guided platforms? How do these differences impact the procedural workflow or your approach to these procedures?
- How do fusion-guided and MRI-targeted biopsy options compare? What are some of the key differences between MRI/US fusion-guided elastic biopsy and MRI-targeted biopsy?
Related Videos
Related Content
Feasibility study explores focal therapy plus radiation in prostate cancer
June 14th 2024Article
"There's obviously a huge interest in focal therapy for prostate cancer, largely because we want to try to prevent the overtreatment of prostate cancer and also develop better approaches to deliver high-quality treatment options for patients," says Timothy D. McClure, MD.
